Allergan plc
AGN.PRA
AGN.PRA was delisted on the 28th of February, 2018.
84 hedge funds and large institutions have $3.17B invested in Allergan plc in 2015 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$575M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$312M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$241M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$235M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$211M |
Top Sellers
AGN.PRA Hedge Fund Activity: Q2 2015 in Review
84 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q2 2015, worth a combined $3.17B.
Buyers outnumbered sellers: 84 funds opened new AGN.PRA positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $575M.
- 84 institutional investors held Allergan plc (AGN.PRA) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $3.17B of Allergan plc stock for Q2 2015.
- 84 funds opened new Allergan plc positions in Q2 2015 and 0 closed out, a net change of +84 holders.
- The largest Allergan plc buyer in Q2 2015 was T. Rowe Price Associates, an estimated $575M added.
Based on aggregated 13F filings for Q2 2015.